Vir Biotechnology (VIR) Research & Development (2018 - 2025)
Vir Biotechnology's Research & Development history spans 8 years, with the latest figure at $88.3 million for Q4 2025.
- On a quarterly basis, Research & Development fell 16.72% to $88.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $456.0 million, a 9.98% decrease, with the full-year FY2025 number at $456.0 million, down 9.98% from a year prior.
- Research & Development hit $88.3 million in Q4 2025 for Vir Biotechnology, down from $151.5 million in the prior quarter.
- Over the last five years, Research & Development for VIR hit a ceiling of $195.2 million in Q3 2024 and a floor of $86.1 million in Q2 2021.
- Historically, Research & Development has averaged $123.2 million across 5 years, with a median of $114.6 million in 2022.
- Biggest five-year swings in Research & Development: soared 107.56% in 2021 and later plummeted 37.46% in 2024.
- Tracing VIR's Research & Development over 5 years: stood at $128.3 million in 2021, then grew by 20.91% to $155.2 million in 2022, then dropped by 29.78% to $109.0 million in 2023, then dropped by 2.65% to $106.1 million in 2024, then decreased by 16.72% to $88.3 million in 2025.
- Business Quant data shows Research & Development for VIR at $88.3 million in Q4 2025, $151.5 million in Q3 2025, and $97.5 million in Q2 2025.